Endotoxin tolerance: new mechanisms, molecules and clinical significance

Trends in Immunology - Tập 30 Số 10 - Trang 475-487 - 2009
Subhra K. Biswas1, Eduardo López‐Collazo2
1Singapore Immunology Network (SIgN), Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), #04-01 Immunos, 8A Biomedical Drive, Singapore 138648
2Unidad de Investigación, Hospital Universitario La Paz, Pseo de La Castellana 261, Madrid 28046, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Nathan, 2002, Points of control in inflammation, Nature, 420, 846, 10.1038/nature01320

Foster, 2009, Gene-specific control of the TLR-induced inflammatory response, Clin. Immunol. (Orlando, FLA), 130, 7, 10.1016/j.clim.2008.08.015

Beutler, 2004, SHIP, TGF-beta, and endotoxin tolerance, Immunity, 21, 134, 10.1016/j.immuni.2004.07.014

O’Neill, 2007, The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling, Nat. Rev. Immunol., 7, 353, 10.1038/nri2079

Biswas, 2007, Role for MyD88-independent, RIF pathway in lipid A/TLR4-induced endotoxin tolerance, J. Immunol., 179, 4083, 10.4049/jimmunol.179.6.4083

Dobrovolskaia, 2002, Toll receptors, CD14, and macrophage activation and deactivation by LPS, Microbes Infect., 4, 903, 10.1016/S1286-4579(02)01613-1

Fan, 2004, Molecular mechanisms of endotoxin tolerance, J. Endotoxin Res., 10, 71, 10.1179/096805104225003997

Cavaillon, 2006, Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis, Crit. Care (London, England), 10, 233, 10.1186/cc5055

Biswas, 2007, Myeloid differentiation factor 88-independent toll-like receptor pathway: sustaining inflammation or promoting tolerance, Int. J. Biochem. Cell Biol. I39, 1582, 10.1016/j.biocel.2007.04.021

del Fresno, 2009, Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients, J. Immunol., 182, 6494, 10.4049/jimmunol.0803350

Foster, 2007, Gene-specific control of inflammation by TLR-induced chromatin modifications, Nature, 447, 972, 10.1038/nature05836

Dobrovolskaia, 2003, Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR “homotolerance” versus “heterotolerance” on NF-kappa B signaling pathway components, J. Immunol., 170, 508, 10.4049/jimmunol.170.1.508

Medvedev, 2000, Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression, J. Immunol., 164, 5564, 10.4049/jimmunol.164.11.5564

Cavaillon, 2003, Endotoxin tolerance: is there a clinical relevance? J, Endotoxin Res., 9, 101, 10.1179/096805103125001487

Monneret, 2008, Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony, Mol. Med. (Cambridge, MA), 14, 64, 10.2119/2007-00102.Monneret

Akira, 2009, Innate immunity to pathogens: diversity in receptors for microbial recognition, Immunol. Rev., 227, 5, 10.1111/j.1600-065X.2008.00739.x

Litvak, 2009, Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals, Nat. Immunol., 10, 437, 10.1038/ni.1721

Chan, 2005, Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter, J. Immunol., 175, 461, 10.4049/jimmunol.175.1.461

Chen, 2009, RelB sustains IkappaBalpha expression during endotoxin tolerance, Clin. Vaccine Immunol., 16, 104, 10.1128/CVI.00320-08

El Gazzar, 2009, Chromatin-specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin tolerance, Mol. Cell Biol., 29, 1959, 10.1128/MCB.01862-08

Mages, 2007, A genome-wide analysis of LPS tolerance in macrophages, Immunobiology, 212, 723, 10.1016/j.imbio.2007.09.015

Draisma, 2009, Development of endotoxin tolerance in humans in vivo, Crit. Care Med., 37, 1261, 10.1097/CCM.0b013e31819c3c67

Monneret, 2004, The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration, Immunol. Lett . 95, 193, 10.1016/j.imlet.2004.07.009

Wolk, 2000, Impaired antigen presentation by human monocytes during endotoxin tolerance, Blood, 96, 218, 10.1182/blood.V96.1.218

Wolk, 2003, Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance, J. Biol. Chem., 278, 18030, 10.1074/jbc.M207714200

Schroder, 2003, Different modes of IL-10 and TGF-beta to inhibit cytokine-dependent IFN-gamma production: consequences for reversal of lipopolysaccharide desensitization, J. Immunol., 170, 5260, 10.4049/jimmunol.170.10.5260

Delano, 2007, MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis, J. Exp. Med., 204, 1463, 10.1084/jem.20062602

Lauw, 2000, Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin, Infect. Immun., 68, 1014, 10.1128/IAI.68.3.1014-1018.2000

Mantovani, 2005, Macrophage polarization comes of age, Immunity, 23, 344, 10.1016/j.immuni.2005.10.001

Sharabi, 2008, Twist-2 controls myeloid lineage development and function, PLoS Biol., 6, e316, 10.1371/journal.pbio.0060316

Albrecht, 2008, Tolerance induced via TLR2 and TLR4 in human dendritic cells: role of IRAK-1, BMC Immunol., 9, 69, 10.1186/1471-2172-9-69

Parker, 2005, Endotoxin tolerance induces selective alterations in neutrophil function, J. Leukoc. Biol., 78, 1301, 10.1189/jlb.0405236

Ogawa, 2003, Mechanisms of endotoxin tolerance in human intestinal microvascular endothelial cells, J. Immunol., 170, 5956, 10.4049/jimmunol.170.12.5956

Buras, 2005, Animal models of sepsis: setting the stage, Nat. Rev., 4, 854, 10.1038/nrd1854

Adib-Conquy, 2009, Compensatory anti-inflammatory response syndrome, Thromb. Haemost., 101, 36, 10.1160/TH08-07-0421

van der Poll, 2008, Host-pathogen interactions in sepsis, Lancet, 8, 32, 10.1016/S1473-3099(07)70265-7

Hotchkiss, 2009, The sepsis seesaw: tilting toward immunosuppression, Nat. Med., 15, 496, 10.1038/nm0509-496

Pachot, 2006, Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study, Immunol. Lett., 106, 63, 10.1016/j.imlet.2006.04.010

Munoz, 1991, Dysregulation of in vitro cytokine production by monocytes during sepsis, J. Clin. Invest., 88, 1747, 10.1172/JCI115493

Munoz, 1991, Dissociation between plasma and monocyte-associated cytokines during sepsis, Eur. J. Immunol., 21, 2177, 10.1002/eji.1830210928

Cavaillon, 2005, Reprogramming of circulatory cells in sepsis and SIRS, J. Endotoxin Res., 11, 311, 10.1177/09680519050110050901

Manjuck, 2000, Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients, J. Lab. Clin. Med., 135, 153, 10.1067/mlc.2000.104306

Hotchkiss, 2003, The pathophysiology and treatment of sepsis, N. Engl. J. Med., 348, 138, 10.1056/NEJMra021333

Serhan, 2007, Resolution of inflammation: state of the art, definitions and terms, FASEB J., 21, 325, 10.1096/fj.06-7227rev

del Fresno, 2005, Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4, J. Immunol., 174, 3032, 10.4049/jimmunol.174.5.3032

Kuang, 2007, Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes, Blood, 110, 587, 10.1182/blood-2007-01-068031

Liu, 2008, High-molecular-weight hyaluronan--a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats, Crit. Care (London, England), 12, R102, 10.1186/cc6982

Adair-Kirk, 2008, Fragments of extracellular matrix as mediators of inflammation, Int. J. Biochem. Cell Biol., 40, 1101, 10.1016/j.biocel.2007.12.005

Fadok, 1998, Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF, J. Clin. Invest., 101, 890, 10.1172/JCI1112

Kelchtermans, 2008, How interferon-gamma keeps autoimmune diseases in check, Trends Immunol., 29, 479, 10.1016/j.it.2008.07.002

Ancuta, 2006, CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells, J. Leukoc. Biol., 80, 1156, 10.1189/jlb.0206125

Ishida, 2008, Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis, J. Immunol., 181, 4208, 10.4049/jimmunol.181.6.4208

Pachot, 2008, Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression, J. Immunol., 180, 6421, 10.4049/jimmunol.180.9.6421

Auffray, 2007, Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior, Science, 317, 666, 10.1126/science.1142883

Fingerle, 1993, The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients, Blood, 82, 3170, 10.1182/blood.V82.10.3170.3170

Sica, 1997, Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes, J. Exp. Med., 185, 969, 10.1084/jem.185.5.969

Hotchkiss, 2002, Depletion of dendritic cells, but not macrophages, in patients with sepsis, J. Immunol., 168, 2493, 10.4049/jimmunol.168.5.2493

Efron, 2004, Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis, J. Immunol., 173, 3035, 10.4049/jimmunol.173.5.3035

Gautier, 2008, Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock, J. Immunol., 180, 6941, 10.4049/jimmunol.180.10.6941

Yamamoto, 2003, Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway, Science, 301, 640, 10.1126/science.1087262

Covert, 2005, Achieving stability of lipopolysaccharide-induced NF-kappaB activation, Science, 309, 1854, 10.1126/science.1112304

Kawai, 1999, Unresponsiveness of MyD88-deficient mice to endotoxin, Immunity, 11, 115, 10.1016/S1074-7613(00)80086-2

Chang, 2007, Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production, J. Immunol., 178, 6705, 10.4049/jimmunol.178.11.6705

Hacker, 2006, Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6, Nature, 439, 204, 10.1038/nature04369

Weighardt, 2006, Type I IFN modulates host defense and late hyperinflammation in septic peritonitis, J. Immunol., 177, 5623, 10.4049/jimmunol.177.8.5623

Jiang, 2005, Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages, Proc. Natl. Acad. Sci. USA, 102, 17077, 10.1073/pnas.0504570102

Sato, 2002, A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways, Int. Immunol., 14, 783, 10.1093/intimm/dxf046

Bjorkbacka, 2004, The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades, Physiol. Genomics, 19, 319, 10.1152/physiolgenomics.00128.2004

Palsson-McDermott, 2009, TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway, Nat. Immunol., 10, 579, 10.1038/ni.1727

Sfeir, 2001, Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock, Crit. Care Med., 29, 129, 10.1097/00003246-200101000-00026

Liew, 2005, Negative regulation of toll-like receptor-mediated immune responses, Nat. Rev. Immunol., 5, 446, 10.1038/nri1630

Lopez-Collazo, 2006, Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state, Curr. Opin. Infect. Dis., 19, 237, 10.1097/01.qco.0000224817.35105.7d

Mashima, 2005, FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling, J. Biol. Chem., 280, 41289, 10.1074/jbc.M508221200

Nimah, 2005, Contribution of MKP-1 regulation of p38 to endotoxin tolerance, Shock, 23, 80, 10.1097/01.shk.0000145206.28812.60

Hayden, 2008, Shared principles in NF-kappaB signaling, Cell, 132, 344, 10.1016/j.cell.2008.01.020

Ziegler-Heitbrock, 2001, The p50-homodimer mechanism in tolerance to LPS, J. Endotoxin Res., 7, 219, 10.1177/09680519010070030401

Adib-Conquy, 2000, NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance, Am. J. Resp. Crit. Care Med., 162, 1877, 10.1164/ajrccm.162.5.2003058

Bohuslav, 1998, Regulation of an essential innate immune response by the p50 subunit of NF-kappaB, J. Clin. Invest., 102, 1645, 10.1172/JCI3877

Wysocka, 2001, IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness, J. Immunol., 166, 7504, 10.4049/jimmunol.166.12.7504

Lawrence, 2001, Possible new role for NF-kappaB in the resolution of inflammation, Nat. Med., 7, 1291, 10.1038/nm1201-1291

Wilson, 2008, Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases, J. Periodontol., 79, 1514, 10.1902/jop.2008.080172

Kayama, 2008, Class-specific regulation of pro-inflammatory genes by MyD88 pathways and IkappaBzeta, J. Biol. Chem., 283, 12468, 10.1074/jbc.M709965200

Saccani, 2002, p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment, Nat. Immunol., 3, 69, 10.1038/ni748

Ramirez-Carrozzi, 2006, Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response, Genes Dev, 20, 282, 10.1101/gad.1383206

Halili, 2009, Histone deacetylase inhibitors in inflammatory disease, Current topics in medicinal chemistry, 9, 309, 10.2174/156802609788085250

Baltimore, 2008, MicroRNAs: new regulators of immune cell development and function, Nat Immunol, 9, 839, 10.1038/ni.f.209

O’Connell, 2007, MicroRNA-155 is induced during the macrophage inflammatory response, Proc Natl Acad Sci U S A, 104, 1604, 10.1073/pnas.0610731104

Taganov, 2006, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc Natl Acad Sci U S A, 103, 12481, 10.1073/pnas.0605298103

Tili, 2007, Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock, J Immunol, 179, 5082, 10.4049/jimmunol.179.8.5082

Costinean, 2006, Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice, Proc Natl Acad Sci U S A, 103, 7024, 10.1073/pnas.0602266103

Bazzoni, 2009, Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals, Proc Natl Acad Sci U S A, 106, 5282, 10.1073/pnas.0810909106

Hao, 2009, The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules, Nat Immunol, 10, 281, 10.1038/ni.1699

Stenvang, 2008, Targeting of microRNAs for therapeutics, Biochemical Society transactions, 36, 1197, 10.1042/BST0361197

Sato, 2000, Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways, J Immunol, 165, 7096, 10.4049/jimmunol.165.12.7096

Buckley, 2006, Cellular reprogramming by gram-positive bacterial components: a review, Journal of leukocyte biology, 80, 731, 10.1189/jlb.0506312

Bagchi, 2007, MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists, J Immunol, 178, 1164, 10.4049/jimmunol.178.2.1164

Kwon, 2004, Fibronectin suppresses apoptosis and protects mice from endotoxic shock, Transplantation proceedings, 36, 2432, 10.1016/j.transproceed.2004.08.058

Kim, 2008, Cross-tolerization between Nod1 and Nod2 signaling results in reduced refractoriness to bacterial infection in Nod2-deficient macrophages, J Immunol, 181, 4340, 10.4049/jimmunol.181.6.4340

Escoll, 2003, Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients, Biochem Biophys Res Commun, 311, 465, 10.1016/j.bbrc.2003.10.019

van 't Veer, 2007, Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model, J Immunol, 179, 7110, 10.4049/jimmunol.179.10.7110

Kobayashi, 2002, IRAK-M is a negative regulator of Toll-like receptor signaling, Cell, 110, 191, 10.1016/S0092-8674(02)00827-9

Rauh, 2005, SHIP represses the generation of alternatively activated macrophages, Immunity, 23, 361, 10.1016/j.immuni.2005.09.003

Zhong, 2008, Decrease in toll-like receptors 2 and 4 in the spleen of mouse with endotoxic tolerance, Inflamm Res, 57, 252, 10.1007/s00011-007-7104-4

del Fresno, 2008, Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism, PLoS ONE, 3, e2667, 10.1371/journal.pone.0002667

Adib-Conquy, 2006, Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients, Crit Care Med, 34, 2377, 10.1097/01.CCM.0000233875.93866.88

del Fresno, 2007, Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes, J Endotoxin Res, 13, 39, 10.1177/0968051907078623

Bouchon, 2001, TREM-1 amplifies inflammation and is a crucial mediator of septic shock, Nature, 410, 1103, 10.1038/35074114

Gibot, 2004, A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis, J Exp Med, 200, 1419, 10.1084/jem.20040708

Rothlin, 2007, TAM receptors are pleiotropic inhibitors of the innate immune response, Cell, 131, 1124, 10.1016/j.cell.2007.10.034

Gilchrist, 2006, Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4, Nature, 441, 173, 10.1038/nature04768

Biswas, 2006, A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation), Blood, 107, 2112, 10.1182/blood-2005-01-0428

Saccani, 2006, p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance, Cancer Res, 66, 11432, 10.1158/0008-5472.CAN-06-1867

Xie, 2007, Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth, Mol Immunol, 44, 3453, 10.1016/j.molimm.2007.03.018

Kawasaki, 2001, Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery, Anesth Analg, 92, 1322, 10.1097/00000539-200105000-00046